Patent Assignment
Reel/Frame 059059/0145
Assignment of Assignor's Interest
Recorded: 2022-02-21
Pages: 7
Assignor
BRISTOL-MYERS SQUIBB COMPANY
Executed: 2011-09-08
Assignee
EXELIXIS, INC.
210 EAST GRAND AVENUE, SOUTH SAN FRANCISCO, CALIFORNIA, 94080-0511
Covered Properties
(2)
Malate salt of N-(4-{[6,7-bis(methyloxy) quinolin-4-yl]oxy}phenyl)-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide, and crystalline forms therof for the treatment of cancer
Application:
17/371,372 →
Publication:
US 2022/0259151
Malate salt of N-(4-{[6,7-bis(methyloxy) quinolin-4-yl]oxy}phenyl)-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide, and crystalline forms thereof for the treatment of cancer
Application:
17/505,275 →
Publication:
US 2022/0033357
Related Assignments
(4)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Feb 21, 2022
From: GALLAGHER, WILLIAM P.
To: BRISTOL-MYERS SQUIBB COMPANY
Reel/Frame 059058/0975 →
Assignment of Assignor's Interest
Feb 21, 2022
From: LAMB, PETER
To: EXELIXIS, INC.
Reel/Frame 059059/0018 →
Assignment of Assignor's Interest
Feb 21, 2022
From: PHARMORPHIX
To: EXELIXIS, INC.
Reel/Frame 059059/0173 →
Assignment of Assignor's Interest
Feb 21, 2022
From: ST. CLAIR BROWN, ADRIAN
To: PHARMORPHIX
Reel/Frame 059059/0193 →